[go: up one dir, main page]

AU5669498A - Farnesyl transferase inhibitors - Google Patents

Farnesyl transferase inhibitors

Info

Publication number
AU5669498A
AU5669498A AU56694/98A AU5669498A AU5669498A AU 5669498 A AU5669498 A AU 5669498A AU 56694/98 A AU56694/98 A AU 56694/98A AU 5669498 A AU5669498 A AU 5669498A AU 5669498 A AU5669498 A AU 5669498A
Authority
AU
Australia
Prior art keywords
transferase inhibitors
farnesyl transferase
farnesyl
inhibitors
transferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56694/98A
Other versions
AU741921B2 (en
Inventor
Jean-Dominique Bourzat
Marc Capet
Michel Cheve
Alain Commercon
Norbert Dereu
Patrick Mailliet
Jean-Paul Martin
Fabienne Sounigo-Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU5669498A publication Critical patent/AU5669498A/en
Application granted granted Critical
Publication of AU741921B2 publication Critical patent/AU741921B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/724,7-Endo-alkylene-iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU56694/98A 1996-12-30 1997-12-23 Farnesyl transferase inhibitors Ceased AU741921B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/16206 1996-12-30
FR9616206A FR2757855B1 (en) 1996-12-30 1996-12-30 NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1997/002407 WO1998029390A1 (en) 1996-12-30 1997-12-23 Farnesyl transferase inhibitors

Publications (2)

Publication Number Publication Date
AU5669498A true AU5669498A (en) 1998-07-31
AU741921B2 AU741921B2 (en) 2001-12-13

Family

ID=9499293

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56694/98A Ceased AU741921B2 (en) 1996-12-30 1997-12-23 Farnesyl transferase inhibitors

Country Status (32)

Country Link
EP (1) EP0948483B1 (en)
JP (1) JP2001509147A (en)
KR (1) KR20000062391A (en)
AR (1) AR008950A1 (en)
AT (1) ATE214367T1 (en)
AU (1) AU741921B2 (en)
BR (1) BR9714498A (en)
CA (1) CA2275943A1 (en)
CO (1) CO4920252A1 (en)
CZ (1) CZ233599A3 (en)
DE (1) DE69711081T2 (en)
DK (1) DK0948483T3 (en)
DZ (1) DZ2389A1 (en)
EA (1) EA002114B1 (en)
ES (1) ES2172033T3 (en)
FR (1) FR2757855B1 (en)
HU (1) HUP0001747A3 (en)
ID (1) ID22922A (en)
IL (1) IL130453A0 (en)
MA (1) MA26460A1 (en)
NO (1) NO993225L (en)
NZ (1) NZ336042A (en)
PE (1) PE28199A1 (en)
PL (1) PL334345A1 (en)
PT (1) PT948483E (en)
SK (1) SK88399A3 (en)
TN (1) TNSN97214A1 (en)
TR (1) TR199901502T2 (en)
UY (1) UY24832A1 (en)
WO (1) WO1998029390A1 (en)
YU (1) YU30299A (en)
ZA (1) ZA9711734B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (en) * 1998-12-21 2003-01-17 Aventis Pharma Sa COMPOSITIONS CONTAINING FARNESYL TRANSFERASE INHIBITORS
FR2796640A1 (en) * 1999-07-22 2001-01-26 Aventis Pharma Sa New 3,9-ethano-2,3,3a,4,9,9a-hexahydro-1H-benzo (f) isoindole derivatives, are farnesyl transferase inhibitors useful for treating hyperproliferative disorders, e.g. psoriasis, restenosis or especially cancer
FR2796641B1 (en) * 1999-07-22 2001-09-21 Aventis Pharma Sa NOVEL PROCESS FOR THE PREPARATION OF BENZOPERHYDROISOINDOLE COMPOUNDS
FR2845994B1 (en) * 2002-10-18 2006-05-19 Servier Lab NOVEL SUBSTITUTED BENZO [E] [1,4] OXAZINO [3,2-G] ISOINDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US20060106060A1 (en) * 2004-03-18 2006-05-18 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies (Lansbury)
WO2024229406A1 (en) 2023-05-04 2024-11-07 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100362338B1 (en) * 1993-11-05 2003-04-08 워너-램버트 캄파니 Protein: Substituted Di- and Tripeptide Inhibitors of Farnesyl Transferase
FR2736641B1 (en) * 1995-07-10 1997-08-22 Rhone Poulenc Rorer Sa NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
UY24832A1 (en) 2001-08-27
ID22922A (en) 1999-12-16
AR008950A1 (en) 2000-02-23
NZ336042A (en) 2000-12-22
FR2757855A1 (en) 1998-07-03
CO4920252A1 (en) 2000-05-29
DZ2389A1 (en) 2002-12-28
ES2172033T3 (en) 2002-09-16
BR9714498A (en) 2000-03-21
EP0948483B1 (en) 2002-03-13
DK0948483T3 (en) 2002-07-01
DE69711081D1 (en) 2002-04-18
PT948483E (en) 2002-08-30
FR2757855B1 (en) 1999-01-29
EP0948483A1 (en) 1999-10-13
IL130453A0 (en) 2000-06-01
TNSN97214A1 (en) 2005-03-15
AU741921B2 (en) 2001-12-13
ATE214367T1 (en) 2002-03-15
HUP0001747A2 (en) 2000-09-28
CA2275943A1 (en) 1998-07-09
NO993225L (en) 1999-08-24
ZA9711734B (en) 1998-06-25
WO1998029390A1 (en) 1998-07-09
DE69711081T2 (en) 2002-08-01
JP2001509147A (en) 2001-07-10
PL334345A1 (en) 2000-02-28
NO993225D0 (en) 1999-06-29
EA002114B1 (en) 2001-12-24
KR20000062391A (en) 2000-10-25
SK88399A3 (en) 2000-05-16
HUP0001747A3 (en) 2000-10-30
TR199901502T2 (en) 1999-09-21
MA26460A1 (en) 2004-12-20
YU30299A (en) 2002-03-18
PE28199A1 (en) 1999-06-05
EA199900608A1 (en) 2000-02-28
CZ233599A3 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
AU6622396A (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
AU2136697A (en) Inhibitors of farnesyl protein transferase
AU3880897A (en) Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
AU703203B2 (en) Inhibitors of farnesyl-protein transferase
AU2734797A (en) Inhibitors of farnesyl-protein transferase
HU9602516D0 (en) Isoprenyl transferase inhibitors
AU2670297A (en) Inhibitors of farnesyl-protein transferase
AU2593097A (en) Inhibitors of farnesyl-protein transferase
AU2253097A (en) Inhibitors of farnesyl-protein transferase
AU2845395A (en) Inhibitors of farnesyl protein transferase
AU2430197A (en) Inhibitors of farnesyl-protein transferase
AU6522496A (en) 4,9-ethanobenzo(F)isoindole derivatives as farnesyl transferase inhibitors
AU5772698A (en) Inhibitors of farnesyl protein transferase
PL330120A1 (en) Farnesilic protein transferase inhibitors
AU7493396A (en) Farnesyl transferase inhibiting 2-quinolone derivatives
AU2555997A (en) Inhibitors of farnesyl-protein transferase
AU2605897A (en) Inhibitors of farnesyl-protein transferase
AU2598897A (en) Inhibitors of farnesyl-protein transferase
AU2552497A (en) Inhibitors of farnesyl-protein transferase
PL348294A1 (en) Farnesyl protein transferase inhibitors
AU2605797A (en) Inhibitors of farnesyl-protein transferase
AU1851697A (en) Inhibitors of farnesyl-protein transferase
AU5129098A (en) Complement inhibitor
AU2587597A (en) Inhibitors of farnesyl-protein transferase
AU5164898A (en) Thioproline-containing inhibitors of farnesyl protein transferase

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired